Chemoinformaics analysis of Methyl 5-phenylvalerate
| Molecular Weight | 192.258 | nRot | 5 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 7 |
| Exact Molecular Weight | 192.115 | nRing | 1 |
| Solubility: LogS | -3.156 | nHRing | 0 |
| Solubility: LogP | 2.975 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 32.3127 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.529 |
| Synth | 1.403 |
| Natural Product Likeliness | 0.104 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.466 |
| MDCK | 0.0000275 |
| BBB | 0.95 |
| PPB | 0.862861 |
| VDSS | 0.96 |
| FU | 0.0839278 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.676 |
| CYP2c19-inh | 0.928 |
| CYP2c19-sub | 0.263 |
| CYP2c9-inh | 0.659 |
| CYP2c9-sub | 0.55 |
| CYP2d6-inh | 0.109 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.134 |
| CYP3a4-sub | 0.357 |
| CL | 10.455 |
| T12 | 0.852 |
| hERG | 0.096 |
| Ames | 0.013 |
| ROA | 0.029 |
| SkinSen | 0.93 |
| Carcinogencity | 0.262 |
| EI | 0.944 |
| Respiratory | 0.134 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.667951 |